Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

732 public trials 133 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

NCT05828069

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 120 locations
View Trial Details
Recruiting

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT07284602

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), +6 more
Locations
  • Palmtree Clinical Research Inc. Palm Spring, California, United States
  • Paradigm Clinical Research Centers LLC Redding, California, United States
  • Infinity Medical Research North Dartmouth, Massachusetts, United States
  • Clinical Research Associates of Central PA DuBois, Pennsylvania, United States
View Trial Details
Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

NCT07230288

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328 Dothan, Alabama, United States
  • Christie Clinic on University /ID# 277871 Champaign, Illinois, United States
  • Hannibal Regional Hospital /ID# 277984 Hannibal, Missouri, United States
  • Centre d'Investigation Clinique Mauricie /ID# 277949 Trois-Rivières, Quebec, Canada
View all 57 locations
View Trial Details
Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT07036523

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Florida Gainesville, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 46 locations
View Trial Details
Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05571059

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Biosolutions Clinical Research La Mesa, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Miami VA Health System Miami, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View all 15 locations
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 72 locations
View Trial Details

Related conditions